Anavex Life Sciences Corp. Outlines its Central Nervous System (CNS) Portfolio of Novel Therapeutics February 1, 2007
Anavex Life Sciences Corp. Acquires a Portfolio of Patents and Appoints Dr. Alexandre Vamvakides as CSO and Director January 31, 2007
Cancer cell cycle modulated by a functional coupling between sigma-1 receptors and Cl-channels. January 26, 2007
Steroid pregnenolone sulfate enhances NMDA-receptor-independent long-term potentiation at hippocampal CA1 synapses: Role for L-type calcium channels and sigma receptors. January 11, 2007
Sigma receptor type 1 gene expression variation in a group of Polish patients with Alzheimer’s disease and mild cognitive impairment. January 10, 2007
Sigma-1 receptor activation prevents intracellular calcium dysregulation in cortical neurons during in vitro ischemia. December 11, 2006
The expression and functional characterization of sigma-1 receptors in breast cancer cell lines. October 28, 2006
Intrathecal treatment with sigma-1 receptor antagonists reduces formalin-induced phosphorylation of NMDA receptor subunit 1 and the second phase of formalin test in mice. June 11, 2006
Cocaine-induced HIV-1 expression in microglia involves sigma-1 receptors and transforming growth factor-beta1. June 11, 2006
Sigma receptor activation reduces infarct size at 24 hours after permanent middle cerebral artery occlusion in rats. May 11, 2006
